Kiryat Tivon, Israel

Dror Alishekevitz

USPTO Granted Patents = 4 

Average Co-Inventor Count = 9.4

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2022-2025

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Dror Alishekevitz: Innovator in Immunotherapy

Introduction

Dror Alishekevitz, an accomplished inventor based in Kiryat Tivon, Israel, has made significant strides in the field of immunotherapy. With three patents to his name, his work focuses on developing methods and compositions to enhance cancer treatment through innovative immune receptor strategies.

Latest Patents

Dror’s latest patents showcase his dedication to advancing cancer therapies. One of his notable patents is centered on methods and compositions for decreasing soluble immune receptor CD28. This patented methodology provides agents capable of binding to membranal immune receptors, inhibiting proteolytic cleavage, and decreasing soluble immune receptor levels for improved cancer immunotherapy. Additionally, Dror holds a patent for monoclonal anti-ILT2 antibodies, which includes pharmaceutical compositions for treating cancer. This work outlines the production of these antibodies and patient selection methods, further emphasizing Dror’s role in innovative cancer treatment strategies.

Career Highlights

Throughout his career, Dror has gained valuable experience working with noteworthy companies such as Biond Biologics Ltd. and Biond Biologies Ltd. His expertise in the biotechnology sector has enabled him to contribute to groundbreaking innovations in the immunotherapy landscape.

Collaborations

Dror has collaborated with notable professionals in the field, including Motti Hakim and Avidor Shulman. These partnerships have fostered a productive environment for research and development, leading to significant advancements in treating cancer through targeted therapies.

Conclusion

Dror Alishekevitz stands out as an influential inventor in the arena of immunotherapy. His innovative patents and collaborative efforts underline his commitment to improving cancer treatments. As the field continues to evolve, his contributions will likely inspire future advancements and innovations in medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…